Application

Trademark

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97115552
Filing Date: 11/09/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97115552
MARK INFORMATION
*MARK BOTOX ONE
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT BOTOX ONE
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Allergan, Inc.
*MAILING ADDRESS 2525 Dupont Drive
*CITY Irvine
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92612
PHONE 714-246-4788
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS  
*IDENTIFICATION Promoting and enhancing healthcare professionals understanding and awareness of botulinum toxin through educational offerings via a website, access to product support, social media, and dissemination of emails in conjunction therewith
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS  
*IDENTIFICATION Providing business information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; assistance to patients regarding treatment payment plan options, namely, business administration of patient reimbursement programs; providing a website via a global computer network featuring consumer information and comprehensive content being consumer product information in the fields of neurology, dermatology and urology; and, distribution of samples for trial purposes in the field of neurology, dermatology and urology
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS  
*IDENTIFICATION Medical advisory services regarding treatment payment plan options including reimbursement of a portion of a patient's out-of-pocket expenses, namely, providing financial administration of patient reimbursement programs; assistance to patients regarding treatment payment plan options, namely, financial administration of patient reimbursement programs; providing financial information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS  
*IDENTIFICATION Providing resources in the nature of educational training courses for healthcare professionals relating to all approved indications of therapeutic treatments and injection instruction in the field of neurology and urology
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS  
*IDENTIFICATION Providing resources in the nature of health information for healthcare professionals relating to all approved indications of therapeutic treatments and injection instruction in the fields of neurology and urology
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS  
*IDENTIFICATION Patient assistance programs that provide medical drugs to help patients with insufficient resources get treatment at little or no cost to the patient
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 5734444, 5734450, 1692384, and others.
CORRESPONDENCE INFORMATION
NAME Allergan, Inc.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE mbrady@abbvie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) susan.hinchey@abbvie.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 6
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 2100
*TOTAL FEES PAID 2100
SIGNATURE INFORMATION
SIGNATURE /mob/
SIGNATORY'S NAME Matthew O. Brady
SIGNATORY'S POSITION Vice President
SIGNATORY'S PHONE NUMBER 714-246-4788
DATE SIGNED 11/09/2021
SIGNATURE METHOD Signed directly within the form



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97115552
Filing Date: 11/09/2021

To the Commissioner for Trademarks:

MARK: BOTOX ONE (Standard Characters, see mark)
The literal element of the mark consists of BOTOX ONE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Allergan, Inc., a corporation of Delaware, having an address of
      2525 Dupont Drive
      Irvine, California 92612
      United States
      714-246-4788(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class _______: Promoting and enhancing healthcare professionals understanding and awareness of botulinum toxin through educational offerings via a website, access to product support, social media, and dissemination of emails in conjunction therewith
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class _______: Providing business information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; assistance to patients regarding treatment payment plan options, namely, business administration of patient reimbursement programs; providing a website via a global computer network featuring consumer information and comprehensive content being consumer product information in the fields of neurology, dermatology and urology; and, distribution of samples for trial purposes in the field of neurology, dermatology and urology
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class _______: Medical advisory services regarding treatment payment plan options including reimbursement of a portion of a patient's out-of-pocket expenses, namely, providing financial administration of patient reimbursement programs; assistance to patients regarding treatment payment plan options, namely, financial administration of patient reimbursement programs; providing financial information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class _______: Providing resources in the nature of educational training courses for healthcare professionals relating to all approved indications of therapeutic treatments and injection instruction in the field of neurology and urology
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class _______: Providing resources in the nature of health information for healthcare professionals relating to all approved indications of therapeutic treatments and injection instruction in the fields of neurology and urology
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class _______: Patient assistance programs that provide medical drugs to help patients with insufficient resources get treatment at little or no cost to the patient
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 5734444, 5734450, 1692384, and others.


The applicant's current Correspondence Information:
      Allergan, Inc.
       PRIMARY EMAIL FOR CORRESPONDENCE: mbrady@abbvie.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): susan.hinchey@abbvie.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $2100 has been submitted with the application, representing payment for 6 class(es).

Declaration

Declaration Signature

Signature: /mob/   Date: 11/09/2021
Signatory's Name: Matthew O. Brady
Signatory's Position: Vice President
Signatory's Phone Number: 714-246-4788
Signature method: Signed directly within the form
Payment Sale Number: 97115552
Payment Accounting Date: 11/09/2021

Serial Number: 97115552
Internet Transmission Date: Tue Nov 09 11:56:59 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202111091156598
12115-97115552-78170ef565149ce559a782852
979e27d6e9ee3397fca5ca382114525fd3712e-D
A-56591981-20211109114344396544

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed